RSVP
MRNA icon

Ramsay Stattman Vela & Price’s Moderna MRNA Stock Holding History

Ramsay Stattman Vela & Price’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,200
Closed -$434K – 79
2023
Q3 		$434K Hold
4,200
– – 0.09% 71
2023
Q2 		$510K Hold
4,200
– – 0.1% 71
2023
Q1 		$645K Hold
4,200
– – 0.14% 70
2022
Q4 		$754K Hold
4,200
– – 0.17% 68
2022
Q3 		$497K Hold
4,200
– – 0.12% 71
2022
Q2 		$600K Buy
4,200
+200
+5% +$28.6K 0.13% 79
2022
Q1 		$689K Buy
+4,000
New +$673K 0.13% 78

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ramsay Stattman Vela & Price's MRNA Position: Q4 2023 in Review

Ramsay Stattman Vela & Price sold out of Moderna (MRNA) in Q4 2023, closing a stake of 4,200 shares — an estimated $434K sold.

Ramsay Stattman Vela & Price first reported a position in MRNA in Q1 2022 and held it in 7 quarters. The position peaked at $754K in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Ramsay Stattman Vela & Price reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Ramsay Stattman Vela & Price sold 4,200 Moderna shares in Q4 2023, an estimated $434K.
  • Ramsay Stattman Vela & Price first reported a position in Moderna in Q1 2022 and held it in 7 quarters.
  • Ramsay Stattman Vela & Price's Moderna position peaked at $754K in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Ramsay Stattman Vela & Price's 13F filing for Q4 2023, filed 1 Feb 2024.